Rationale Dopamine (DA) receptor stimulation in the nucleus accumbens (NAc) plays an important role in regulating cocaine-seeking behavior. Adenosine receptors antagonize the effects of DA receptor stimulation on intracellular signaling, neuronal output, and behavior. Objectives The goal of the present study is to determine the effects of adenosine A 2A receptor stimulation on reinstatement of cocaine-seeking behavior in rats. Methods Rats were trained to lever press for cocaine in daily self-administration sessions on a fixed-ratio 1 schedule for 3 weeks. After 1 week of abstinence, lever pressing was extinguished in six daily extinction sessions. We subsequently assessed the effects of the adenosine A 2A receptor agonist, CGS 21680, on cocaine-, quinpirole (D 2 agonist)-, and cueinduced reinstatement to cocaine seeking. We also assessed the effects of CGS 21680 on sucrose seeking in rats extinguished from sucrose self-administration. Results Pretreatment of CGS 21680 dose-dependently blunted cocaine-induced reinstatement (15 mg/kg, i.p.). Pretreatment with CGS 21680 (0.03 mg/kg, i.p.) also attenuated quinpirole-and cue-induced reinstatement. A minimally effective dose of CGS 21680 failed to alter cocaine-induced locomotor activity or sucrose seeking. Conclusions Stimulation of adenosine A 2A receptors antagonizes reinstatement of cocaine seeking elicited by cocaine, DA D 2 -receptor stimulation, and cocaine-conditioned cues. These findings suggest that adenosine A 2A receptor stimulation may oppose DA D 2 receptor signaling in the NAc that mediates cocaine relapse.
Introduction
Relapse to drug seeking is induced by exposure to drugassociated cues and pharmacological stimuli that activate the mesolimbic dopamine (DA) system (Shalev et al. 2002) . The mesolimbic DA system is composed of DA cells in the ventral tegmental area (VTA) that terminate in forebrain regions such as the nucleus accumbens (NAc). DA release in the NAc targets two major classes of DA receptors that are differentiated by their opposing effects on intracellular signaling cascades. DA D 1 receptors increase adenylyl cyclase activity, while DA D 2 receptors decrease activity of this enzyme (Lachowicz and Sibley 1997) . These DA receptor subtypes are also distinguished by differential expression patterns on distinct subtypes of NAc neurons. Although there is evidence for co-localization in the same neurons (Aizman et al. 2000; Schwartz et al. 1998) , D 1 receptors exist primarily on neurons expressing substance P and dynorphin, whereas D 2 receptors exist primarily on neurons expressing enkephalin. These two distinct populations of NAc neurons differ in their projection targets and reflect the direct and indirect striatal output pathways, respectively (Aubert et al. 2000; Lu et al. 1998; Steiner and Gerfen 1998) .
Chronic cocaine self-administration increases behavioral responses mediated by DA D 2 receptors. Thus, repeated cocaine administration produces cross-sensitization with DA D 2 receptor agonists (Ujike et al. 1990) and animals with high self-regulated cocaine intake patterns display greater D 2 receptor-induced locomotion (Edwards et al. 2007 ). In addition, reinstatement of cocaine seeking is elicited by systemic and intra-NAc stimulation of D 2 receptors (Bachtell et al. 2005; De Vries et al. 1999; Dias et al. 2004; Khroyan et al. 2000; Self et al. 1996) . Thus, amplification of D 2 -mediated behaviors following chronic cocaine administration may enhance relapse elicited by cocaine-conditioned cues and pharmacological stimuli by targeting D 2 receptors (Cervo et al. 2003; Gal and Gyertyan 2006) . Tempering enhancements in D 2 receptor-mediated behaviors following cocaine administration may provide effective treatments for curbing relapse vulnerability.
Adenosine functions as a neuromodulator of dopamine neurotransmission and recent studies suggest that stimulation of adenosine A 2A receptors oppose many behavioral effects of cocaine. Thus, stimulation of A 2A receptors reduces both the development and expression of cocaine sensitization (Filip et al. 2006) and impairs the initiation of cocaine self-administration (Knapp et al. 2001) . Adenosine A 2A receptor antagonists, on the other hand, exacerbate cocaine sensitization (Filip et al. 2006 ) and enhance cocaine-evoked discriminative stimulus effects . While the exact mechanisms of these A 2A receptor effects are not known, they may involve reciprocal regulation of DA D 2 receptors through receptor heteromerization and/or opposing intracellular signaling cascades .
Adenosine A 2A receptors are primarily localized to striatal regions in the brain where they are co-expressed with DA D 2 receptors on enkephalin-containing neurons (Dixon et al. 1996; Fink et al. 1992; Svenningsson et al. 1998) . Interestingly, A 2A and D 2 receptors exert a number of effects that oppose one another on intracellular signaling cascades, cellular functioning, and behavioral responses. Stimulation of A 2A receptors decreases the affinity of D 2 receptors for dopamine (Ferre et al. 1991b) , counteracts D 2 receptor-mediated signal transduction (Yang et al. 1995) , opposes the effects of DA receptor stimulation on immediate early gene expression in the striatum (Morelli et al. 1994; Svenningsson et al. 1999a) , and reverses D 2 -induced inhibition of GABA output to the pallidum (Ferre et al. 1993) . Consequently, adenosine A 2A receptor stimulation exerts behavioral effects that are functionally similar to DA receptor antagonists (Barraco et al. 1993; Brown et al. 1991; Heffner et al. 1989; Rimondini et al. 1997; Zarrindast et al. 1993) .
Based on the aforementioned relationship between A 2A and D 2 receptors, stimulation of A 2A receptors would decrease DA neurotransmission and consequently relapse behaviors mediated by D 2 receptor signaling. In the present set of experiments, we tested the hypothesis that stimulation of adenosine A 2A receptors will blunt cocaine seeking using an animal model of relapse. We trained animals to selfadminister cocaine and tested the effects of adenosine A 2A receptor stimulation on cocaine seeking following extinction training. The effects of adenosine A 2A receptor stimulation were evaluated on cocaine seeking elicited by cocaine, the D 2 receptor agonist, quinpirole, and cocaineassociated cues. We used the A 2A agonist, CGS 21680, to stimulate A 2A adenosine receptors since the specificity of CGS 21680 binding to A 2A receptors in nucleus accumbens is abolished in adenosine A 2A but not A 1 receptor knockout mice (Halldner et al. 2004) , and is widely used as a ligand for stimulating striatal adenosine A 2A receptors (Cunha et al. 1996; Jarvis et al. 1989 ). In addition, recent work has demonstrated that motor depression induced by the A 2A agonist, CGS 21680, but not the A 1 agonist, N 6 -cyclopentyladenosine, was specifically blocked by the A 2A antagonist, MSX-3, and not an A 1 -specific antagonist (Karcz-Kubicha et al. 2003) .
Materials and methods

Animals and housing conditions
Male Sprague-Dawley rats initially weighing 275-325 g (Charles River Laboratories, Kingston, NY, USA) were individually housed in wire cages with food and water available ad libitum. Experiments were conducted during the light cycle of a 12:12-h light:dark cycle (lights on at 0700 hours) in accordance with guidelines established by the National Institute of Health and the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center.
Cocaine self-administration procedure Self-administration and reinstatement testing were performed in operant conditioning chambers (Med-Associates, St. Albans, VT, USA) equipped with two response levers and an infusion pump system as previously described (Edwards et al. 2007 ). Animals were initially trained to lever press for sucrose pellets to facilitate acquisition of cocaine self-administration. These rats were food restricted to prevent weight gain, and trained to lever press for sucrose pellets on a fixed ratio 1 (FR1) reinforcement schedule until acquisition criteria had been achieved (100 sucrose pellets in two consecutive sessions). After leverpress training, animals were fed ad libitum for at least 1 day prior to surgical implantation with a chronic intrajugular catheter as previously described (Self et al. 1998 ).
Following at least 5-7 days' recovery from surgery, animals were allowed to self-administer intravenous cocaine (0.5 mg/kg/50 μl injection) on a fixed ratio 1 (FR1) reinforcement schedule in daily 4-h sessions for 5-6 days/ week. Cocaine injections were delivered over 2.5 s concurrent with the illumination of a cue light above the active lever, and followed by an additional 12.5-s time out period (TO 15 s) when the house light remained off and responding was without consequence. Inactive lever responses produced no consequence throughout testing.
Extinction/reinstatement testing After a minimum of 15 cocaine self-administration sessions, animals remained in their home cages for 7 days of abstinence. On days 8-13 of abstinence, animals returned to the operant conditioning chambers for extinction training in the absence of cocaine reinforcement in 4-h test sessions. Responses on the lever that previously delivered cocaine injections during self-administration (drug-paired lever) and on the inactive lever were recorded but had no programmed drug or cue delivery.
Cocaine-primed reinstatement
The effects of adenosine A 2A receptor stimulation on cocaine-primed reinstatement was tested over repeated reinstatement sessions to allow for testing of several doses of the A 2A agonist (0.01, 0.03, 0.1, and 0.3 mg/kg, i.p.). Each test session was initiated with 3 h of extinction conditions followed by a 1-h reinstatement test period. A pretreatment of the A 2A receptor agonist, CGS 21680 (vehicle, 0.01, 0.03, 0.1, 0.3 mg/kg, i.p.), was administered 5 min prior to a priming injection of cocaine (15 mg/kg, i.p.), which was followed by a 1-h reinstatement test. Animals received a maximum of four treatments in a randomized order although different dose ranges were tested spanning the five doses. All animals were tested under the vehicle pretreatment/cocaine reinstatement condition to provide a baseline of cocaine-primed reinstatement. However, all animals did not receive all doses of CGS 21680 due to concerns of residual testing and weakening of reinstatement responding over repeated trials. Responses at both drug-paired and inactive levers were recorded but produced no cue or drug delivery during testing.
Cue-induced reinstatement
In a separate set of animals, we tested the effects of adenosine A 2A receptor stimulation on reinstatement elicited by cocaine-associated cues. Cue-induced reinstatement of cocaine-seeking behavior was measured in a 4-h reinstatement session consisting of 3 h of extinction conditions followed by a 1-h cue-primed reinstatement test period. A pretreatment of vehicle or 0.03 mg/kg CGS 21680 was administered 5 min prior to the cue reinstatement test. This dose was used because it proved most effective in blunting cocaine-induced reinstatement, while having little sedative effects. The cue-induced reinstatement test was initiated with non-contingent (priming) presentation of the cocaine injection cues delivered every 2 min for the first 10 min. During the entire session, responding at the drug-paired lever resulted in response-contingent cue delivery (2.5 s illumination of cue light and infusion pump, 15 s termination of house light).
Quinpirole-induced reinstatement
In separate study groups, the effect of adenosine A 2A receptor stimulation on dopamine D 2 receptor-primed relapse behavior was assessed. Given the longer duration of quinpirole action relative to cocaine, priming injections of quinpirole (0, 0.1, 0.3, and 1.0 mg/kg, s.c.) were given before the final 2 h of the session immediately after 2 h of extinction conditions. A pretreatment of CGS 21680 (0.03 mg/kg, i.p.) was administered 5 min prior to quinpirole treatment. Quinpirole doses were administered in randomized order across test days. Responses at both levers were recorded, but resulted in no cue or cocaine delivery.
Sucrose reinstatement
Animals were trained to self-administer sucrose pellets on an FR1:TO 15-s schedule as described above. After 15 daily sessions (100 pellets/session), animals remained in their home cages for 7 days of "abstinence", and were then subjected to extinction training in six daily 4-h sessions. Following extinction training, animals were tested for reinstatement of sucrose seeking. A pretreatment of CGS 21680 (0.03 mg/kg, i.p.) was administered 5 min prior to sucrose reinstatement testing. Reinstatement testing was initiated by non-contingent sucrose pellet delivery in a single 1-h test immediately following 1 h of extinction conditions. During the reinstatement phase, animals were presented with the non-contingent delivery of a sucrose pellet every 2 min for 1 h (30 pellets/1 h). Responding at both levers was recorded, but resulted in no cues or sucrose pellet delivery.
Locomotor testing
Locomotor activity was recorded in darkened circular test chambers with a 12-cm-wide runway, equipped with four pairs of photocells located at 90°intervals around the 1.95-m perimeter. All locomotor tests were performed during the light phase of the light:dark cycle. Five days following cocaine self-administration and reinstatement procedures, animals were habituated to the locomotor testing apparatus for 2 h on the day prior to cocaineinduced locomotor activity testing. On the test day, animals were again habituated for 2 h, given a pretreatment of vehicle or CGS 21680 (0.03 mg/kg, i.p.) and administered a cocaine challenge (15 mg/kg, i.p.) 5 min later. Locomotor activity was assessed for 2 h.
Data analysis
Cocaine-induced reinstatement data (lever presses) were analyzed with a mixed design two-factor ANOVA with lever (within) and CGS 21680/cocaine treatment (between) as the factors. Quinpirole-induced reinstatement data (lever presses) were analyzed with a two-factor ANOVA with quinpirole and CGS pretreatment as the factors. Cue-and sucrose-induced reinstatement data (lever presses) were analyzed with a mixed design two-factor ANOVA with the within factor, reinstatement (extinction vs. cue/sucrose), and the between factor, pretreatment. The effect of CGS 21680 pretreatment on cocaine-induced locomotor activity (beam breaks) was analyzed by an unpaired t test. All interactive effects of the ANOVAs were followed by simple main effects analyses (one-way ANOVA) and post hoc tests (Bonferroni's comparisons, Dunnett's test or t test). Statistical significance was preset at p<0.05. 
Results
Adenosine A 2A receptor stimulation dose-dependently blocks cocaine-induced reinstatement Figure 1 illustrates that administration of the adenosine A 2A agonist CGS 21680 dose-dependently reduced cocaineinduced drug seeking. A significant treatment×lever interaction (F 5,50 =5.47, p<0.001) and significant main effects of treatment (F 5,50 =5.07, p<0.001) and lever (F 1,50 =26.32, p< 0.001) were observed. Subsequent analysis of the interaction found that cocaine treatment significantly induced drug-paired lever pressing, which was dosedependently decreased by pretreatment with CGS 21680 (F 5,50 =5.29, p<0.001). A statistical trend for reduced inactive lever pressing following the treatments was observed (F 5,50 =2.25, p=0.06).
Because systemic administration of CGS 21680 produces sedation and reduced sensitized locomotor activity to psychostimulants (Filip et al. 2006; Rimondini et al. 1997) , we tested the effects of the minimally effective dose of CGS 21680 (0.03 mg/kg, i.p.) on cocaine-stimulated locomotor activity. These tests were performed in the same animals that had self-administered cocaine and were tested for cocaine-induced reinstatement. As shown in Fig. 2 , pretreatment of CGS 21680 had no effect on cocaineinduced locomotion at the same dose (15 mg/kg) used for cocaine priming in reinstatement (t 22 <1, NS).
Adenosine A 2A receptor stimulation blunts quinpirole-induced reinstatement Systemic administration of DA D 2 receptor agonists robustly stimulates reinstatement of cocaine seeking in extinguished animals. Therefore, we tested whether a pretreatment of CGS 21680 (0.03 mg/kg, i.p.) would attenuate quinpirole-induced reinstatement using the minimum dose effective at blocking cocaine priming. Figure 3 illustrates the dose-dependent increase in drug-paired lever pressing resulting from quinpirole administration, which was attenuated by a pretreatment with 0.03 mg/kg CGS 21680. Significant main effects of pretreatment (F 1,44 = 8.44, p<0.006) and quinpirole (F 3,44 =14.29, p<0.001) were observed; however, the interaction was not significant (F 3,44 =1.68, p=0.18) . No effects of quinpirole or pretreatment were observed in inactive lever pressing (data not shown).
Adenosine A 2A receptor stimulation reduces cue-induced reinstatement
Presentation of cocaine-associated cues is sufficient to elicit reinstatement of cocaine seeking in extinguished animals. Because this is mediated in part by DA transmission in the striatum, we tested whether a pretreatment of CGS 21680 (0.03 mg/kg, i.p.) would block cue-induced reinstatement. Figure 4 illustrates that a CGS 21680 pretreatment significantly blunts cue-induced reinstatement. While both pretreatment groups displayed significant increases in drug-paired lever pressing during the cue presentations compared to the preceding hour of extinction (Cue-F 1,15 =40.61, p<0.001) , the CGS 21680 group responded at significantly lower levels (Pretreatment-F 1,15 =7.49, p<0.02; Cue×Pretreatment-F 1,15 =8.28, p<0.02). No effects of the cue presentation or CGS 21680 pretreatment were observed on inactive lever responding (data not shown).
Adenosine A 2A receptor stimulation has no effect on sucrose seeking Finally, we incorporated a procedural control to account for any generalized performance effects of CGS 21680 (0.03 mg/kg, i.p.) on reinstatement using non-contingent delivery of sucrose pellets in animals trained to selfadminister sucrose pellets. Figure 5 illustrates that a pretreatment of CGS 21680 had no effect on sucrose reinstatement (Pretreatment-F 1,13 <1, NS; Sucrose×Pre-treatment-F 1,13 <1, NS), despite the significant levels of sucrose-induced lever pressing (Sucrose-F 1,13 =11.97, p< 0.005), which was comparable to cue-induced reinstatement following cocaine self-administration.
Discussion
These findings demonstrate for the first time that pharmacological activation of adenosine A 2A receptors attenuates cocaine-seeking behavior. We show that A 2A receptor activation reduces cocaine seeking induced by pharmacological stimuli such as cocaine and quinpirole and also by discrete cocaine-associated cues. These findings agree with previous work demonstrating that A 2A stimulation attenuated the development and expression of behavioral sensitization to cocaine and methamphetamine (Filip et al. 2006; Shimazoe et al. 2000) , the expression of cocaine place conditioning (Poleszak and Malec 2002) , and the initiation Fig. 2 Cocaine-induced locomotor activity was unaltered by a pretreatment with CGS 21680. a Time course of locomotor activity illustrating the last 30 min of the habituation period (90-110 min) followed by the effects of 15 mg/kg cocaine (i.p.) with and without a pretreatment of 0.03 mg/kg CGS 21680 (i.p.). This dose was chosen since it was the lowest dose that was effective in reducing cocaineinduced reinstatement (Fig. 1) . b Cocaine-induced locomotor activity over the first hour in animals pretreated with vehicle or 0.03 mg/kg CGS 21680 (i.p.). No significant changes in locomotor activity were observed, n=12/group of cocaine self-administration (Knapp et al. 2001 ). Other complementary work utilizing pharmacological blockade of adenosine A 2A receptors also supports an antagonistic effect of A 2A receptors on cocaine-mediated behaviors. Thus, antagonists of A 2A receptors enhanced the acute locomotor effects of cocaine, the development, and the subsequent expression of cocaine sensitization (Filip et al. 2006) . Previous studies also showed a reversal in intracranial self-stimulation current threshold impairments observed during cocaine withdrawal, further suggesting that A 2A receptor antagonism alters behavioral indices of withdrawal observed during abstinence (Baldo et al. 1999; Filip et al. 2006 ). Together, these findings suggest that adenosine A 2A receptor stimulation oppose the effects of cocaine and cocaine-associated cues. Our findings that CGS 21680 completely abolished drug-paired lever pressing establish the potential beneficial effects of adenosine A 2A receptor stimulation on cocaine-induced cocaine-seeking behavior, although cocaine seeking elicited by the D 2 agonist, quinpirole, or cocaine-associated cues was only partially attenuated.
Other work utilizing genetic deletion of the adenosine A 2A receptor report conflicting evidence and paradoxically display behavioral effects similar to those utilizing pharmacological stimulation. Thus, mice lacking the A 2A receptor display attenuated locomotor responses to cocaine, impaired development of amphetamine sensitization, and reductions in the reinforcing efficacy of self-administered cocaine (Chen et al. 2000; Chen et al. 2003; Soria et al. 2006) . These findings may result from compensatory changes during development or may reflect the lack of neuroanatomical specificity of A 2A receptor knockdown in neural circuits regulating these behaviors. Recent work supports the latter since extra-striatal (forebrain) knockdown of A 2A receptors reduced psychostimulant-induced locomotion, while striatal-specific knockdown of A 2A receptors enhanced psychostimulant-induced locomotion akin to pharmacological antagonism (Shen et al. 2008 ). These findings further suggest an inhibitory role for adenosine A 2A receptors specifically in the striatum; however, further study will be required to ascertain the site of action for reducing cocaine seeking.
Stimulation of the adenosine A 2A receptors is known to activate dopamine D 2 -and enkephalin-containing neurons in the striatum that form the indirect pathway (KarczKubicha et al. 2006) . Thus, local stimulation of A 2A Fig. 4 Administration of the adenosine A 2A receptor agonist CGS 21680 blunted reinstatement induced by cocaine-associated cues. a Number of cocaine infusions in each 4-h session during the cocaine self-administration phase. b Extinction training was performed in six daily sessions 1 week following the last self-administration session. Responses on the previously drug-paired lever (solid lines) were reduced to levels comparable to inactive lever responses (dotted lines). c Cueinduced reinstatement testing was conducted in a 4-h reinstatement session that included an initial extinction phase (3 h) that preceded the reinstatement phase (1 h). Shown in the figure is the third hour of the extinction phase and the following hour of cue testing. The A 2A agonist, CGS 21680, significantly reduced cue-induced drug-paired lever responding. *Significant from extinction (p<0.05, Bonferroni post test). Bar-significant from 0 CGS 21680 pretreatment (t 15 =3.12, p<0.01), Vehicle N=8; CGS 21680 N=9 receptors in the dorsal and ventral striatum enhances GABA input to the globus pallidus and ventral pallidum, respectively (Mingote et al. 2008; Ochi et al. 2000) . It is plausible that A 2A receptor stimulation antagonizes the heightened sensitivity of dopamine D 2 receptors in the striatum following long-term cocaine administration. In this manner, A 2A receptor stimulation acts similarly to a D 2 receptor antagonist in blocking the functional inhibition of indirect striatal GABA output mediated by D 2 receptors.
Not only are A 2A and D 2 receptors co-localized on the enkephalin-containing neurons as previously described, the receptors play an antagonistic and reciprocal role in modulating cellular function (Ferre 1997; Ferre et al. 1991a (Yang et al. 1995) and opposes the effects of DA receptor stimulation on immediate early gene expression in the striatum (Morelli et al. 1994; Svenningsson et al. 1999a ). Thus, A 2A receptor-induced activation of stimulatory G proteins and increases in cAMP production would consequently increase neuron excitability and effectively offset D 2 receptor effects mediated by inhibitory G proteins (Colwell and Levine 1995; Schiffmann et al. 2007; Svenningsson et al. 1999a; Tozzi et al. 2007 ). Some of the opposing effects also may be dictated by the formation of heteromeric receptor complexes between postsynaptic A 2A and D 2 receptors Fuxe et al. 2003; Hillion et al. 2002) . The formation of A 2A /D 2 receptor complexes provides inhibitory regulation over dopamine D 2 receptor binding and inhibitory G-protein coupling (Ferre et al. 1991a; Fuxe et al. 1998; Hillion et al. 2002; Torvinen et al. 2005) . The relative contribution of heteromerized and non-heteromerized A 2A and D 2 receptors to counteract D 2 -mediated signaling remains unclear, especially in the context of addiction.
Alternatively, it is possible that presynaptic A 2A receptors located on glutamate terminals in striatum indiscriminately alter the striatal neuronal function since local injections of CGS 21680 have been shown to increase striatal glutamate release (Corsi et al. 1999; Rodrigues et al. 2005) . However, previous work has demonstrated that stimulation of AMPA glutamate receptors in the NAc induces drug seeking (Cornish et al. 1999 ) while blockade of AMPA receptors attenuates cocaine-and cue-induced drug seeking (Backstrom and Hyytia 2007; Cornish et al. 1999) . It therefore does not seem likely that presynaptic A 2A receptor stimulation resulting in striatal glutamate release would mediate a reduction in cocaine seeking.
It is also possible that the effects of systemic CGS 21680 administration on the reinstatement behavior shown here are mediated by A 2A receptors located outside of the striatum. While adenosine A 2A receptors are most abundant in striatal regions, low to moderate levels of A 2A receptors are found in other regions such as the medial prefrontal cortex and the amygdala (Svenningsson et al. 1999b ). These two regions also receive dopaminergic innervation that is known to be involved in cocaine seeking (McFarland and Kalivas 2001) , and A 2A receptor stimulation within these structures may similarly modulate dopamine transmission. Stimulation of A 2A receptors in the prefrontal cortex decreased sedation time and electroencephalographic activity, both measures of increased arousal (Van Dort et al. 2009 ), which were not observed in the present study with the most effective dose of CGS 21680. The effect of A 2A Fig. 5 Administration of the adenosine A 2A receptor agonist CGS 21680 had no effect on sucrose seeking. a Sucrose self-administration was conducted over 3 weeks. b Extinction training was performed in six daily sessions 1 week following the last self-administration session. Responses on the previously sucrose-paired lever (solid line) were reduced to levels comparable to inactive lever responses (dotted line). c Sucrose reinstatement testing was conducted in a 2-h reinstatement session that included an initial extinction phase (1 h) that preceded the reinstatement phase (1 h). The A 2A agonist, CGS 21680, failed to alter sucrose seeking despite significant responding on the lever previously paired with sucrose delivery. *Significant from extinction (p<0.05, Dunnett's test), Vehicle N=7, CGS 21680 N=8 receptor stimulation in the amygdala is unclear. Given the amygdala's involvement in cue-induced cocaine seeking, one may predict that stimulation of A 2A receptors in the amygdala would blunt cue-induced cocaine seeking perhaps through similar antagonism of D 2 receptors as found in the striatum. Future studies will be necessary to fully elucidate the involvement of A 2A receptors in specific brain circuits regulating drug seeking.
In conclusion, our findings suggest an important antagonistic role for adenosine A 2A receptor stimulation in mediating cocaine relapse behaviors. We demonstrate that stimulation of A 2A receptors blunts cocaine seeking induced by pharmacological and conditioned stimuli in an animal model of relapse. These findings support the notion that this effect involves a negative interaction between adenosine A 2A receptors and relapse mediated by D 2 receptor stimulation. Together, these findings suggest that enhancing the inhibitory regulation of dopamine D 2 receptors may provide an effective pharmacological treatment strategy.
